NCT00654550View on ClinicalTrials.gov

A Study to Assess the Safety, Tolerability and Effect of Nexagon™ Applied to the Eye After PRK Laser Eye Surgery for Nearsightedness

PHASE1CompletedINTERVENTIONAL
Enrollment

24

Participants

Timeline

Start Date

April 30, 2008

Primary Completion Date

September 30, 2008

Study Completion Date

December 31, 2008

Conditions
Corneal re-Epithelialization
Interventions
DRUG

Nexagon™ or Nexagon™ vehicle

Dose-escalation design in which cohorts of 6 subjects will be studied sequentially.

Trial Locations (1)

1001

Auckland Eye Limited, Auckland

Sponsors
All Listed Sponsors
lead

OcuNexus Therapeutics, Inc.

INDUSTRY